Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models
1. Department of Gynecology, Medical School, Goethe University, Frankfurt (Main), Germany
2. Department of Bioinformatics and Department of Pediatrics, Semmelweis University, Budapest, Hungary
3. Department of Biophysics, Medical School, University of Pecs, Pecs, Hungary
4. HUN-REN TTK Cancer Biomarker Research Group, Budapest, Hungary
5. Translational Genomics, Department of Ophthalmology, University Hospital Essen, Essen, Germany
6. German Cancer Consortium (DKTK) at University Hospital Essen and German Cancer Research Center (DKFZ), Heidelberg, Germany
7. Institute for Veterinary Anatomy, Histology and Embryology, Giessen, Germany
8. Georg-Speyer-Haus, Goethe University, Frankfurt, Germany
9. German Cancer Consortium (DKTK) at Goethe University Frankfurt and German Cancer Research Center (DKFZ), Heidelberg, Germany
Sanhaji@med.uni-frankfurt.de
strebhardt@em.uni-frankfurt.de
Show less